LATEST NEWS & PUBLICATIONS

An article in the Washington Post co-authored by University of Minnesota health policy professor Sarah Gollust analyzes the bill that passed the US House of Representatives last week.

Over the past 20 years, a preserve known as Pleistocene Park has been created in Siberia with the goal of restoring grasslands once home to megafauna like mammoths.

A DNA analysis of 14 horse skeletons preserved in Russian and Kazakh sites reveals the Scythians, who ruled the area more than 2,000 years ago, were sophisticated breeders. Fierce, nomadic warriors, the Scythians are believed to be among the first to ride horses into battle, helping extend their territory over large parts of Eastern Europe and Central Asia.

Videos are now available for sessions held during the two research ethics conferences presented at the University of Minnesota on March 8 and 9, 2017.

Last week, the Consortium hosted the final of three lectures on Emerging Diseases in a Changing Environment, featuring Dr. Julie L. Gerberding, MD, MPH, FACP. Dr. Gerberding is Executive Vice President at Merck and the former Director of the Centers for Disease Control and Prevention (CDC). In her talk, she described what she's learned about emergency preparedness through responses to anthrax, SARS and other biothreats, and proposed steps that should be taken to improve such responses.

In a turnaround for the Food and Drug Administration (FDA), the agency has announced it will "allow a company to sell genetic tests for disease risk directly to consumers," according to the New York Times. 23andMe, a private genomics and biotechnology company based in Mountain View, California, pioneered products to allow customers to learn about their genome without the involvement of a doctor, genetic counselor

Given the drama of the past several weeks, during which Congress wrestled with repealing, replacing or reforming the Affordable Care Act (ACA), it's an opportune time to look at the trajectory of that legislation. On March 23, the seventh anniversary of the ACA's signing, the former General Counsel for the US Department of Health and Human Services (HHS), William B.

Multisite clinical trials are a powerful way to drive the discovery of new therapies, but ensuring that the health and privacy of study participants are protected across multiple Institutional Review Boards (IRBs) has slowed things down in the past.

Renowned epidemiologist Michael T. Osterholm, PhD, MPH, director of Consortium member the Center for Infectious Disease Research and Policy (CIDRAP), has published a new book laying out how humanity can protect itself against catastrophic infectious disease and pandemic. In Deadliest Enemy: Our War Against Killer Germs, Prof.

A symposium published today on Bill of Health, a blog edited by the Petrie-Flom Center at Harvard Law School, expands on discussions held at the Consortium's Deinard Memorial Lecture last December, "How Patients Are Creating Medicine’s Future." The Deinard lecture featured four speakers&nbs